Phase 1 Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are between 18 and 64 years old (inclusive) at the time of signing the consent form
- People whose Body Mass Index (BMI) — a measure of body weight relative to height — falls between 27.0 and 34.9, where the extra weight is due to excess body fat as determined by the study doctor
- People who are considered generally healthy based on their medical history, a physical check-up, and results from heart, vital signs, and blood/lab tests done at the screening visit, as judged by the study doctor
Who may not be able to join:
- People who have previously been enrolled (randomised) into a clinical study involving a type of medication called an amylin analogue
- People who have any condition that, in the study doctor's opinion, could put them at risk or make it difficult to safely follow the study requirements (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Clinical Transparency (dept. 2834), Novo Nordisk A/S
Phone: (+1) 866-867-7178
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
AUC,ss: area under the total cagrilintide concentration-time curve at steady state after 5th dosing of cagrilintide s.c.; Cmax,ss: maximum concentration of total cagrilintide at steady state after 5th dosing of cagrilintide s.c.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.